Planning and Informatics / Arthur Andersen & Company / CDER / Shared Services / /
Currency
USD / /
Event
Reorganization / /
Facility
FDA Headquarters / Laboratory Employees / FDA’s HQ / /
IndustryTerm
time-reporting systems / on-line time reports / human drug applications / telecommunications / manufacturing facilities / finance / /
Organization
Legislation office of Policy / Operations Office / office of Executive Programs / Minority Health office of Women / office of Planning and Informatics / Immediate Office / Division of Cost Determination Management / Women’s Health Office / office of Shared Services / office of Medical Products and Tobacco / office of Finance / National Center for Toxicological Research / office of Global Regulatory Operations and Policy / office of Regulatory Affairs / Commissioner Office / External Affairs Office / Center for Tobacco Products / Executive Secretariat Office / CBER / FDA / office of Communications / ORA / Food Safety / Chief Counsel Office / Center for Drug Evaluation and Research / Department of Health and Human Services / Center for Veterinary Medicine / office of Shared Services FTE / office of the Secretary / Center for Biologics Evaluation and Research / Center for Device and Radiological Health / office of Management / CDER mission / /
Position
Chief Scientist / Counselor / President / Commissioner / Agency General / Director of the Center / Secretary / /
APPENDIX D DEVELOPMENT OF COSTS FOR THE PROCESS FOR THE REVIEW OF HUMAN DRUG APPLICATIONS GENERAL METHODOLOGY The costs associated with the process for the review of human drug applications are based on obligations recor